FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

MOONLAKE IMMUNOTHERAPEUTICS: cashflow_investing

One fact, its scope and the complete path back to the official record.

Period: 2025-01-01 – 2025-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/5ac284e0-7ba0-46f7-9b27-6bf0e5f343f4

Reported value

$202.992M{"amount": 202992000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Entity
MOONLAKE IMMUNOTHERAPEUTICS
Metric
cashflow_investing
Period
2025-01-01 – 2025-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001821586-26-000002 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T18:19:59.360224+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001821586/cashflow-investing/2025-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.